Saturday, October 28
10:30 a.m. - 1:00 p.m.
F1
The Role of Pharmacogenetics in Youth with Maladaptive Aggression
Kirti Saxena, M.D.
University of Texas Southwestern Medical Center
Dallas, TX
Erika Torres, B.S.
Linda Mora, B.A.
Steve S.L. The
Joachim Hallmayer, M.D.
Hans Steiner, M.D.
F2
Open-Label Study of Aripiprazole in Asperger's Disorder and PDD NOS
Kimberly A. Stigler, M.D.
Indiana University School of Medicine
Indianapolis, IN
Johnathan T. Diener, B.S.
Arlene E. Kohn, B.A.
David J. Posey, M.D.
Christopher J. McDougle, M.D.
F3
Impact of Obsessive-Compulsive Disorder on Anti-manic Response of Pediatric Bipolar Disorder to Second Generatio Atypitcal Antipsychotics
Gagan Joshi, M.D.
Massachusetts General Hospital
Boston, MA
Eric O. Mick, Sc.D.
Janet Wozniak, M.D.
Daniel A. Geller, MBBS, FRACP
Jennifer Park, B.A.
Joseph Biederman, M.D.
F4
"Manically Obsessive or Obsessively Manic" That's the Question! Examining Clinical Characteristics and Association between Comorbid Bipolar and Obsessive Compulsive Disorder in Youth
Gagan Joshi, M.D.
Massachusetts General Hospital
Boston, MA
Janet Wozniak, M.D.
Daniel A. Geller, MBBS, FRACP
Petty Carter, M.A.
Fe Vivas, M.A.
Lauren Schnare, B.A.
Joseph Biederman, M.D.
F5
Gyrification on VCFS Subjects in Comparison to Siblings and Controls
Arun Kunwar, M.D.
SUNY Upstate Medical University
Syracuse, NY
Wendy Kates, Ph.D.
F6
FMRI Studies of Affect, Paradigm 2: Faces
Andrew J. Gerber, M.D., Ph.D.
Columbia University College of Physicians and Surgeons
New York, NY
Daniel A. Gorman, M.D.
Jonathan Posner, M.D.
Bradley S. Peterson, M.D.
F7
FMRI Studies of Affect, Paradigm 1: Emotion Terms
Jonathan Posner, M.D.
Columbia University/New York State Psychiatric Institute
New York, NY
Daniel A. Gorman, M.D.
Andrew J. Gerber, M.D., Ph.D.
Clancy Blair, Ph.D.
Bradley S. Peterson, M.D.
F8
Genetic Association of Piccolo Gene with Autism in Korea
Geon-Ho Bahn, M.D., Ph.D.
Kyung-Hee University
Seoul, Korea
Shihwan Chang
SH Yoon
Eunyoung Ha
Min Nam, M.D.
Joo-Ho Chung, M.D.
F12
Thalamic Abnormalities in Autism: Structural MRI and 1H MRS Findings
Antonio Y. Hardan, M.D.
Stanford University
Stanford, CA
Nacy J. Minshew, M.D.
Jeffrey A. Stanley, Ph.D.
Matcheri S. Keshavan, M.D.
Sumana Srihari, M.D.
Jeff J. Nutche, B.A.
F13
Korean Autism Prevalence Study: Preliminary Results of Screening with ASSQ
Young Shin Kim, M.D., M.P.H., Ph.D.
Yale University
New Haven, CT
Yun-Joo Koh, Ph.D.
Richard R. Grinker, Ph.D.
Dong-Ho Song, M.D.
Eun-Jung Lim, M.S.
Young-Key Kim, M.D.
Won Cheol Shin, M.D.
Bennett L. Leventhal, M.D.
F14
Adaptive Behavior in Children with Autism and ADHD Symptoms
Deborah A. Pearson, Ph.D.
University of Texas Medical School - Houston
Houston, TX
Katherine A. Loveland, Ph.D.
Cynthia W. Santos, M.D.
Charles D. Casat, M.D.
David Lachar, Ph.D.
David M. Lane, Ph.D.
Rosleen Mansour, M.A.
Stacy Reddoch, B.A.
Jessica Kelly
Lynne A. Cleveland
F15
ADHD Symptomatology in Autism: Concordance of Diagnostic Instruments
Deborah A. Pearson, Ph.D.
University of Texas Medical School - Houston
Houston, TX
Katherine A. Loveland, Ph.D.
Cynthia W. Santos, M.D.
David M. Lane, Ph.D.
Rosleen Mansour, M.A.
Stacy Reddoch, B.A.
Jessica Kelly
Lynne A. Cleveland
F16
Is Being Overweight Related to Medication Use in PDD?
Richard P. Malone, M.D.
Drexel University College of Medicine
Philadelphia, PA
Pazder Rachel
Mary A. Delaney, M.D.
H. Huntley Hardison, M.D.
Hyman B Susan, Ph.D.
Cynthia Gifford, M.S.N.
Lauren Davis, B.A.
F17
Preference for Complex Social Stimuli in Children with Autism
Anke Prothmann, M.D.
University of Leipzig
Leipzig, Germany
Anna C. Brattig, M.D.
Christine Ettrich, M.D., Ph.D.
Sascha Prothmann, M.D.
F18
Clinical Evidence That Asperger's Disorder Is a Mild Form of Autism
Edward R. Ritvo, M.D.
UCLA Medical School
Los Angeles, CA
Riva A. Ritvo, Ph.D.
F19
Neuropsychological Differences in Autistic Children with and without Comorbid ADHD
J. K. Sinzig, M.D.
University of Cologne
Cologne, Germany
Dagmar Morsch, M.S.
Gerd Lehmuhl, M.D.
F20
The Autism Epidemic: Fact or Artifact?
Ashley Wazana, M.D., F.R.C.P.
Centre Hosptalier de la Vallee de l'Or
Quebec, PQ, Canada
Michealine Bresnahan, Ph.D.
Jennie Kline, Ph.D.
F22
Psychosocial and Genetic Factors in Children of Alchoholics in Korea
Keun-Ah Cheon, M.D., Ph.D.
Kwandong University
Korea
Jin-Yong Jun, M.D.
Jae-Won Kim, M.D.
Kee Namkoong, M.D.
F23
Childhood Cortisol Response and Adolescent Substance Abuse in ADHD Youth
Virginia A. Fresiello, B.A.
The Graduate Center of the City University of New York
New York, NY
Carlin J. Miller, Ph.D.
Jeffrey H. Newcorn, M.D.
Jeffrey M. Halperin, Ph.D.
F24
Adolescent Utilities and Substance Treatment Selection
Kristie M. Ladegard, M.D.
Brody School of Medicine at East Carolina Univ.
greenville, NC
John M. Diamond, M.D.
Richard M. Bloch, Ph.D.
Jonathan Scarff
F25
Biological Measures of Treatment Response in Depressed, Substance Abusing Adolescents
Michelle A. Lohman, B.S., R.N.
University of Colorado Health Sciences Center
Denver, CO
Paula D. Riggs, M.D.
Mark L. Laudenslager, Ph.D.
Susan K. Mikulich-Gilbertson, Ph.D.
Shannon K. Stover, B.S.
Heather D. Orton, M.S.
F26
Admitting Having a Drug Problem: Brazilian Youth in Detention Centers
John D. McLennan, M.D., Ph.D.
University of Calgary
Calgary, AB, Canada
Fatima Rigato, M.D.
Isabel A.S. Bordin, M.D.
Merlin B. Brinkerhoff, Ph.D.
Katherine Bennett, Ph.D.
F27
Differential Treatment Outcomes in Prescription Opioid- Versus Heroin-Dependent Adolescents
Mehran Motamed, M.D.
St. Luke's - Roosevelt Hospital Center
New York, NY
Lisa A. Marsch, Ph.D.
Ramon Solhkhah, M.D.
F29
Gender Differences in Treatment Outcome among Opioid-Dependent Adolescents
Ramon Solhkhah, M.D.
St. Luke's - Roosevelt Hospital Center
New York, NY
Lisa A. Marsch, Ph.D.
Adnan Khan, M.D.
Marjorie Waldbaum, M.D.
F30
Improvement in Psychopathology among Opioid-Dependent Adolescents during Bahavioral-
Pharmacological Treatment
Marjorie Waldbaum, M.D.
The Child and Family Institute at St. Luke's and Roosevelt Hospitals
New York, NY
Lisa A. Marsch, Ph.D.
Ramon Solhkhah, M.D.
Amina Chowdury, M.D.
F31
Self-Medication with Cigarettes and Substances in Individuals with ADHD
Timothy E. Wilens, M.D.
Massachusetts General Hospital
Boston, MA
Alison Santry, B.A.
Julia Whitley, B.A.
Stephanie Sgambati, B.A.
Joseph Biederman, M.D.
Joel J. Adamson, B.A.
F32
ADHD in Youths in Substance Abuse Residential Treatment
T. Wolanczyk, M.D., Ph.D.
Medical University of Warsaw
warsaw, poland
E. Stawicka, M.D.
F33
Marijuana Use, Craving, and Withdrawal in Older Adolescent Non-Treatment Seeker
Kevin M. Gray, M.D.
Medical University of South Carolina
Charleston, SC
Himanshu P. Upadhyaya, MBBS, M.S.
F34
Reanalysis of Neuroimaging Data in Relation to Adolescent Substance Use
Iliyan S. Ivanov, M.D.
Mount Sinai School of Medicine
New York, NY
Kurt P. Schulz, Ph.D.
Suzanne M. Clerkin, B.A.
Jin Fan, Ph.D.
Jeffrey H. Newcorn, M.D.
Jeffrey M. Halperin, Ph.D.
F35
Beck Depression Inventory for Depression Screening in Substance Abusing Adolescents
Geetha A. Subramaniam, M.D.
Johns Hopkins University School of Medicine
Baltimore, MD
Maxine L. Stitzer, Ph.D.
Paul Harrell, B.S.
Haley Brown, B.S.
Marc Fishman, M.D.
Phillip Clemmey, Ph.D.
F36
Adoption of an Evidence-Based Treatment for Adolescent Substance Use Disorder into a Community
Christian C. Thurstone, M.D.
University of Colorado Health Sciences Center
Denver, CO
Paula D. Riggs, M.D.
Constance A. Klein, MSW, LCSW
Sara Schwab, L.C.S.W.
F37
Adjustment of Adolescents of Parents Living with HIV
Nancy S. Wu, M.D.
Center for Communicty Health, UCLA
Los Angeles, CA
Suzanne Slocum, Ph.D.
Laura Franzke, Ph.D., M.P.H.
Mary Jane Rotheram-Borus, Ph.D.
Patricia E. Lester, M.D.
F38
Crack/Cocaine Use among Adolescents and HIV Associated Risk
Larry K. Brown, M.D.
Bradley/Hasbro Children's Research Center
Providence, RI
Marina Tolou-Shams, Ph.D.
Nancy Beausoleil, B.A.
F39
Psychiatric Symptoms in Perinatally HIV-Infected Children: Preliminary Findings
Jerry D. Heston, M.D.
St. Jude Children's Research Hospital
Memphis, TN
Paige L. Williams, Ph.D.
Kenneth D. Gadow, Ph.D.
Miriam Chernoff, Ph.D.
Janice Hodge, R.N., B.S.
Sharon Nachman, M.D.
F40
CDT Predicts Heavy Drinking Days in Adolescent Alcoholics: Preliminary Data
Rashim K. Gupta
Medical University of South Carolina
Charleston, SC
Suzanne Thomas, Ph.D.
Natalie G. Johnson, M.A.
Raymond Anton
Deborah Deas, M.D., M.P.H.
F41
Study of Pre and Post Lamotrigine Effects on Neurocognitive Function in Children with Pediatric Bipolar Disorder
Ambar A. Afshar, B.S.
University of Illinois at Chicago
Chicago, IL
M. Marlow-O'Connor, Ph.D.
E. Harral, B.A.
M. Moss, B.A.
J. Sweney, Ph.D.
Mani N. Pavuluri, M.D., Ph.D., FRANZCP
F42
Child and Adolescent Psychiatric Care Accessibility
John Sullivan
University of Texas Medical Branch
Galveston, TX
Karen D. Wagner, M.D., Ph.D.
F43
Play Interactions in Mothers and Infants/Toddlers with Feeding Disorders
Faith R. Rowland, B.S.
The George Washington University
Washington, DC
Irene Chatoor-Koch, M.D.
Jody Ganiban, Ph.D.
Amy Hahn, B.A.
Alexandra Citrin
Lauren Lederer
Lindsay White
F44
Self-Affirming Interventions and Academic Resiliancy
David E. Myles, B.S.
Yale University
Hamden, CT
Valerie Purdie-Vaughns, Ph.D.
Andres S. Martin, M.D.
F45
Life Quality of Depressed, Somatically Ill, and Average Child Populations
Eniko Kiss, M.D.
Szeged University
Szeged, Hungary
Dora Skulteti
Agnes Vetro, M.D., Ph.D.
F46
Scale for Children's Affective Reactivity: Psychometrics, Replication, and Extension
Raymond J. Pan, M.D.
Western Psychiatric Institute & Clinic
Pittsburgh, PA
Boris Birmaher, M.D.
Mary B. Ehmann, B.S.
David J. Kolko, Ph.D.
F47
Double-Blind, Placebo-Controlled, Cross-Over Trial of Subcutaneous Methylcobalamin in Autism: Preliminary Results
Robert L. Hendren, D.O.
University of California - Davis
Sacramento, CA
Lesley Deprey, Ph.D.
Norman Brule, B.S.
F. Widjaja, B.S.
Sarvenaz Sepehri, B.S.
Jeremy A. Blank, B.S.
James Neubrander, M.D.
F48
Cognitive Behavioral Group Therapy for Adolescents with Attention-Deficit/Hyperactivity Disorder
Jeanie T. Tse, M.D.
McGill University
Montreal, PQ, Canada
Vicki Tagalakis, M.Ed.
Lily Hechtman, M.D., FRCP
